Michèle Bouloy

8.8k total citations · 2 hit papers
121 papers, 6.9k citations indexed

About

Michèle Bouloy is a scholar working on Infectious Diseases, Ecology, Evolution, Behavior and Systematics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michèle Bouloy has authored 121 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Infectious Diseases, 51 papers in Ecology, Evolution, Behavior and Systematics and 33 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michèle Bouloy's work include Viral Infections and Vectors (99 papers), Viral Infections and Outbreaks Research (56 papers) and Vector-Borne Animal Diseases (51 papers). Michèle Bouloy is often cited by papers focused on Viral Infections and Vectors (99 papers), Viral Infections and Outbreaks Research (56 papers) and Vector-Borne Animal Diseases (51 papers). Michèle Bouloy collaborates with scholars based in France, United States and Germany. Michèle Bouloy's co-authors include Robert M. Krug, Stephen J. Plotch, Agnès Billecocq, Pierre Vialat, Ramon Flick, Ismo Ulmanen, Rolf Müller, Janusz T. Pawęska, Michel Pépin and Brian H. Bird and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Michèle Bouloy

121 papers receiving 6.7k citations

Hit Papers

A unique cap(m7GpppXm)-de... 1981 2026 1996 2011 1981 2010 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michèle Bouloy France 44 5.1k 2.5k 1.8k 1.5k 1.1k 121 6.9k
Richard M. Elliott United Kingdom 50 4.7k 0.9× 3.0k 1.2× 2.1k 1.2× 792 0.5× 743 0.7× 117 6.2k
Connie S. Schmaljohn United States 51 6.7k 1.3× 2.3k 0.9× 1.9k 1.1× 3.1k 2.1× 539 0.5× 116 7.6k
Joel M. Dalrymple United States 38 4.3k 0.8× 1.1k 0.4× 2.5k 1.4× 1.1k 0.7× 526 0.5× 69 5.6k
D. H. L. Bishop United States 44 2.7k 0.5× 1.3k 0.5× 1.0k 0.6× 298 0.2× 2.0k 1.8× 109 6.3k
Alain Kohl United Kingdom 45 3.2k 0.6× 1.2k 0.5× 2.9k 1.7× 286 0.2× 1.1k 1.0× 141 5.6k
Hideki Ebihara United States 49 5.2k 1.0× 609 0.2× 916 0.5× 535 0.4× 634 0.6× 139 6.7k
César G. Albariño United States 39 3.8k 0.8× 997 0.4× 937 0.5× 507 0.3× 313 0.3× 95 4.4k
David H.L. Bishop United States 37 2.1k 0.4× 1.1k 0.4× 606 0.3× 173 0.1× 910 0.8× 94 3.6k
Tetsuro Ikegami United States 32 3.4k 0.7× 1.4k 0.5× 724 0.4× 897 0.6× 392 0.3× 86 3.8k
Ν. James MacLachlan United States 52 5.1k 1.0× 5.1k 2.0× 452 0.3× 193 0.1× 316 0.3× 204 8.3k

Countries citing papers authored by Michèle Bouloy

Since Specialization
Citations

This map shows the geographic impact of Michèle Bouloy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michèle Bouloy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michèle Bouloy more than expected).

Fields of papers citing papers by Michèle Bouloy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michèle Bouloy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michèle Bouloy. The network helps show where Michèle Bouloy may publish in the future.

Co-authorship network of co-authors of Michèle Bouloy

This figure shows the co-authorship network connecting the top 25 collaborators of Michèle Bouloy. A scholar is included among the top collaborators of Michèle Bouloy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michèle Bouloy. Michèle Bouloy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valle, Tânia Zaverucha do, Dominique Simon‐Chazottes, Laurent Guillemot, et al.. (2015). The genetic basis for susceptibility to Rift Valley fever disease in MBT/Pas mice. Genes and Immunity. 16(3). 206–212. 12 indexed citations
2.
Coupanec, Alain Le, et al.. (2014). Clone 13-infected Aedes aegypti salivary components inhibit Rift Valley fever virus pathogenicity. Microbes and Infection. 16(5). 439–444. 1 indexed citations
3.
Carnec, Xavier, et al.. (2013). Role of the cytosolic tails of Rift Valley fever virus envelope glycoproteins in viral morphogenesis. Virology. 448. 1–14. 24 indexed citations
4.
Ceianu, Cornelia Svetlana, et al.. (2012). First Serologic Evidence for the Circulation of Crimean-Congo Hemorrhagic Fever Virus in Romania. Vector-Borne and Zoonotic Diseases. 12(9). 718–721. 32 indexed citations
5.
Gommet, Céline, Agnès Billecocq, Grégory Jouvion, et al.. (2011). Tissue Tropism and Target Cells of NSs-Deleted Rift Valley Fever Virus in Live Immunodeficient Mice. PLoS neglected tropical diseases. 5(12). e1421–e1421. 51 indexed citations
6.
Lozach, Pierre‐Yves, Andreas Kühbacher, Roger Meier, et al.. (2011). DC-SIGN as a Receptor for Phleboviruses. Cell Host & Microbe. 10(1). 75–88. 184 indexed citations
7.
Chinikar, Sadegh, et al.. (2010). Geographical Distribution and Surveillance of Crimean-Congo Hemorrhagic Fever in Iran. Vector-Borne and Zoonotic Diseases. 10(7). 705–708. 71 indexed citations
8.
Moutailler, Sara, et al.. (2010). Replication of Clone 13, a Naturally Attenuated Avirulent Isolate of Rift Valley Fever Virus, in Aedes and Culex mosquitoes. Vector-Borne and Zoonotic Diseases. 10(7). 681–688. 11 indexed citations
9.
Pépin, Michel, Janusz T. Pawęska, & Michèle Bouloy. (2010). Diagnostic specificity of ELISA-based tests for the detection of antibodies to Rift Valley Fever virus in French ruminants. Revue Méd Vét. 161(3). 104–107. 3 indexed citations
10.
Cêtre-Sossah, Catherine, Agnès Billecocq, Renaud Lancelot, et al.. (2009). Evaluation of a commercial competitive ELISA for the detection of antibodies to Rift Valley fever virus in sera of domestic ruminants in France. Preventive Veterinary Medicine. 90(1-2). 146–149. 13 indexed citations
11.
Billecocq, Agnès, et al.. (2008). RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses. Virology. 378(2). 377–384. 97 indexed citations
12.
Moutailler, Sara, Michèle Bouloy, & Anna‐Bella Failloux. (2007). Short report: efficient oral infection of Culex pipiens quinquefasciatus by Rift Valley fever virus using a cotton stick support.. PubMed. 76(5). 827–9. 17 indexed citations
13.
Bouloy, Michèle, et al.. (2006). Abstract 1460: Effect of HMR1766, a Soluble Guanylate Cyclase Activator, on Differentiation of Cardiac Fibroblasts and Extracellular Matrix Synthesis Induced by TGFbeta. Circulation. 114. 1 indexed citations
14.
Zaki, Ali M., et al.. (2005). Production of monoclonal antibodies against Rift Valley fever virus. Journal of Virological Methods. 131(1). 34–40. 23 indexed citations
15.
Tang, Qing, Christophe Préhaud, & Michèle Bouloy. (1999). Sequencing and analysis of S gene segment of XHFV. Zhonghua weishengwuxue he mianyixue zazhi. 19(6). 461–465. 4 indexed citations
16.
Vialat, Pierre, et al.. (1998). Molecular Epidemiology and Emergence of Rift Valley Fever. Memórias do Instituto Oswaldo Cruz. 93(5). 609–614. 15 indexed citations
17.
Préhaud, Christophe, et al.. (1997). Analysis of the 3′ Terminal Sequence Recognized by the Rift Valley Fever Virus Transcription Complex in Its Ambisense S Segment. Virology. 227(1). 189–197. 37 indexed citations
18.
Desprès, Philippe, Andrés Ruiz‐Linares, Annie Cahour, et al.. (1990). The 15 amino acid residues preceding the amino terminus of the envelope protein in the yellow fever virus polyprotein precursor act as a signal peptide. Virus Research. 16(1). 59–75. 4 indexed citations
19.
Young, Alan R., et al.. (1981). Direct Vascular Effects of Agents Used in the Pharmacotherapy of Cerebrovascular Disease on Isolated Cerebral Vessels. Journal of Cerebral Blood Flow & Metabolism. 1(1). 117–128. 22 indexed citations
20.
Bouloy, Michèle, Stephen J. Plotch, & Robert M. Krug. (1978). Globin mRNAs are primers for the transcription of influenza viral RNA in vitro. Proceedings of the National Academy of Sciences. 75(10). 4886–4890. 217 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026